RxDoctor Payments DataLook up a doctor →

David Heimansohn, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Indianapolis, INNPI 1598784001

Payments from drug & device makers

$1,490,346in general payments, 2019–2025

Across 341 payments — averaging $4370.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1M
  • Medtronic$204K
  • Abbott$144K
  • Corcym Inc$66K
  • Livanova USA, Inc.$63K
  • Boston Scientific$9K
  • plus $3K from 3 others

What the payments were for

  • Consulting fees$4,11324%
  • Speaking & faculty fees$2,40014%
  • Travel & lodging$6,78239%
  • Food & beverage$4,19924%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences126$1,000,568
Medtronic(2 entities)108$204,392
Abbott54$143,949
Corcym Inc7$65,911
Livanova USA, Inc.28$63,361
Boston Scientific13$9,192
Atricure, Inc.3$2,851
Pfizer1$73
Covidien LP1$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,490,346 in reported general payments places this provider in the 95th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana

Medicare billing

Part B allowed, 2024
$453,425
Medicare patients
267
Services billed
636

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Warfarin Sodium39$157
Amoxicillin100$112
Potassium Chloride17$63
Azithromycin23$24
Furosemide12$16

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →